Literature DB >> 29270329

Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Dorothy A Kieffer1, Valentina Medici1.   

Abstract

Environmental factors, including diet, exercise, stress, and toxins, profoundly impact disease phenotypes. This review examines how Wilson disease (WD), an autosomal recessive genetic disorder, is influenced by genetic and environmental inputs. WD is caused by mutations in the copper-transporter gene ATP7B, leading to the accumulation of copper in the liver and brain, resulting in hepatic, neurological, and psychiatric symptoms. These symptoms range in severity and can first appear anytime between early childhood and old age. Over 300 disease-causing mutations in ATP7B have been identified, but attempts to link genotype to the phenotypic presentation have yielded little insight, prompting investigators to identify alternative mechanisms, such as epigenetics, to explain the highly varied clinical presentation. Further, WD is accompanied by structural and functional abnormalities in mitochondria, potentially altering the production of metabolites that are required for epigenetic regulation of gene expression. Notably, environmental exposure affects the regulation of gene expression and mitochondrial function. We present the "multi-hit" hypothesis of WD progression, which posits that the initial hit is an environmental factor that affects fetal gene expression and epigenetic mechanisms and subsequent "hits" are environmental exposures that occur in the offspring after birth. These environmental hits and subsequent changes in epigenetic regulation may impact copper accumulation and ultimately WD phenotype. Lifestyle changes, including diet, increased physical activity, stress reduction, and toxin avoidance, might influence the presentation and course of WD, and therefore may serve as potential adjunctive or replacement therapies.

Entities:  

Keywords:  Epigenetics; Mitochondria; Modifier gene; Wilson disease

Year:  2017        PMID: 29270329      PMCID: PMC5734098          DOI: 10.1016/j.livres.2017.08.003

Source DB:  PubMed          Journal:  Liver Res


  174 in total

1.  Wilson disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes.

Authors:  Martina Ralle; Dominik Huster; Stefan Vogt; Wiebke Schirrmeister; Jason L Burkhead; Tony R Capps; Lawrence Gray; Barry Lai; Edward Maryon; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

2.  HFE gene mutations and Wilson's disease in Sardinia.

Authors:  Orazio Sorbello; Margherita Sini; Alberto Civolani; Luigi Demelia
Journal:  Dig Liver Dis       Date:  2009-07-28       Impact factor: 4.088

Review 3.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 4.  Food derived microRNAs.

Authors:  Anika E Wagner; Stefanie Piegholdt; Martin Ferraro; Kathrin Pallauf; Gerald Rimbach
Journal:  Food Funct       Date:  2015-03       Impact factor: 5.396

5.  Wilson disease in septuagenarian siblings: Raising the bar for diagnosis.

Authors:  Aftab Ala; Jimo Borjigin; Arnold Rochwarger; Michael Schilsky
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.

Authors:  J A Lebrón; A P West; P J Bjorkman
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

7.  Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators.

Authors:  Perla Kaliman; María Jesús Alvarez-López; Marta Cosín-Tomás; Melissa A Rosenkranz; Antoine Lutz; Richard J Davidson
Journal:  Psychoneuroendocrinology       Date:  2013-11-15       Impact factor: 4.905

8.  The effects of fructose on adenosine triphosphate depletion following mitochondrial dysfunction and lethal cell injury in isolated rat hepatocytes.

Authors:  J R Cannon; P J Harvison; G F Rush
Journal:  Toxicol Appl Pharmacol       Date:  1991-05       Impact factor: 4.219

9.  Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency.

Authors:  Ulrich Salzer; Tina Hagena; David B Webster; Bodo Grimbacher
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

10.  Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo.

Authors:  Christian T Sheline; Eric H Choi; Jeong-Sook Kim-Han; Laura L Dugan; Dennis W Choi
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  9 in total

Review 1.  Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Authors:  Sabine Weiskirchen; Philipp Kim; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2019-04

2.  Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.

Authors:  Gaurav V Sarode; Kyoungmi Kim; Dorothy A Kieffer; Noreene M Shibata; Tomas Litwin; Anna Czlonkowska; Valentina Medici
Journal:  Metabolomics       Date:  2019-03-12       Impact factor: 4.290

Review 3.  Connecting copper and cancer: from transition metal signalling to metalloplasia.

Authors:  Eva J Ge; Ashley I Bush; Angela Casini; Paul A Cobine; Justin R Cross; Gina M DeNicola; Q Ping Dou; Katherine J Franz; Vishal M Gohil; Sanjeev Gupta; Stephen G Kaler; Svetlana Lutsenko; Vivek Mittal; Michael J Petris; Roman Polishchuk; Martina Ralle; Michael L Schilsky; Nicholas K Tonks; Linda T Vahdat; Linda Van Aelst; Dan Xi; Peng Yuan; Donita C Brady; Christopher J Chang
Journal:  Nat Rev Cancer       Date:  2021-11-11       Impact factor: 69.800

Review 4.  Wilson Disease: Update on Pathophysiology and Treatment.

Authors:  Som Dev; Robert L Kruse; James P Hamilton; Svetlana Lutsenko
Journal:  Front Cell Dev Biol       Date:  2022-05-02

5.  Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease.

Authors:  Shubhrajit Roy; Prosenjit Pal; Sampurna Ghosh; Sreyashi Bhattacharya; Shyamal Kumar Das; Prasanta Kumar Gangopadhyay; Ashish Bavdekar; Kunal Ray; Mainak Sengupta; Jharna Ray
Journal:  Neuromolecular Med       Date:  2018-07-10       Impact factor: 3.843

6.  A genome-wide association study for harness racing success in the Norwegian-Swedish coldblooded trotter reveals genes for learning and energy metabolism.

Authors:  Brandon D Velie; Kim Jäderkvist Fegraeus; Marina Solé; Maria K Rosengren; Knut H Røed; Carl-Fredrik Ihler; Eric Strand; Gabriella Lindgren
Journal:  BMC Genet       Date:  2018-08-29       Impact factor: 2.797

7.  A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats.

Authors:  Claudia Einer; Christin Leitzinger; Josef Lichtmannegger; Carola Eberhagen; Tamara Rieder; Sabine Borchard; Ralf Wimmer; Gerald Denk; Bastian Popper; Frauke Neff; Elena V Polishchuk; Roman S Polishchuk; Stefanie M Hauck; Christine von Toerne; Jennifer-Christin Müller; Uwe Karst; Bipin S Baral; Alan A DiSpirito; Andreas E Kremer; Jeremy Semrau; Karl Heinz Weiss; Simon Hohenester; Hans Zischka
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-12-23

8.  Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage.

Authors:  Silvano Junior Santini; Giovanni Tarantino; Antonella Iezzi; Anna Alisi; Clara Balsano
Journal:  Nutr Metab (Lond)       Date:  2022-02-11       Impact factor: 4.169

9.  Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.

Authors:  Oriol De Fabregues; Jaume Viñas; Antoni Palasí; Manuel Quintana; Ignasi Cardona; Cristina Auger; Víctor Vargas
Journal:  Brain Behav       Date:  2020-03-22       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.